Atlas Trials

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Clinical trial NCT01637272 · COMPLETED

Trial details

NCT number
NCT01637272
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dumping Syndrome
Start date
2013-01-08
Primary completion
2015-08-07
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.